SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation

Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 12; no. 1; pp. 4664 - 17
Main Authors Pan, Pan, Shen, Miaomiao, Yu, Zhenyang, Ge, Weiwei, Chen, Keli, Tian, Mingfu, Xiao, Feng, Wang, Zhenwei, Wang, Jun, Jia, Yaling, Wang, Wenbiao, Wan, Pin, Zhang, Jing, Chen, Weijie, Lei, Zhiwei, Chen, Xin, Luo, Zhen, Zhang, Qiwei, Xu, Meng, Li, Geng, Li, Yongkui, Wu, Jianguo
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 02.08.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. N protein facilitates maturation of proinflammatory cytokines and induces proinflammatory responses in cultured cells and mice. Mechanistically, N protein interacts directly with NLRP3 protein, promotes the binding of NLRP3 with ASC, and facilitates NLRP3 inflammasome assembly. More importantly, N protein aggravates lung injury, accelerates death in sepsis and acute inflammation mouse models, and promotes IL-1β and IL-6 activation in mice. Notably, N-induced lung injury and cytokine production are blocked by MCC950 (a specific inhibitor of NLRP3) and Ac-YVAD-cmk (an inhibitor of caspase-1). Therefore, this study reveals a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation and induces excessive inflammatory responses. SARS-CoV-2 infection has been shown to drive NLRP3 inflammasome activation and thereby cytokine storm, but how it does so is unclear. Here the authors show that the viral N protein can bind to NLRP3, resulting in enhanced interaction with ASC and thereby with the NLRP3 inflammasome.
AbstractList Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. N protein facilitates maturation of proinflammatory cytokines and induces proinflammatory responses in cultured cells and mice. Mechanistically, N protein interacts directly with NLRP3 protein, promotes the binding of NLRP3 with ASC, and facilitates NLRP3 inflammasome assembly. More importantly, N protein aggravates lung injury, accelerates death in sepsis and acute inflammation mouse models, and promotes IL-1β and IL-6 activation in mice. Notably, N-induced lung injury and cytokine production are blocked by MCC950 (a specific inhibitor of NLRP3) and Ac-YVAD-cmk (an inhibitor of caspase-1). Therefore, this study reveals a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation and induces excessive inflammatory responses.SARS-CoV-2 infection has been shown to drive NLRP3 inflammasome activation and thereby cytokine storm, but how it does so is unclear. Here the authors show that the viral N protein can bind to NLRP3, resulting in enhanced interaction with ASC and thereby with the NLRP3 inflammasome.
Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. N protein facilitates maturation of proinflammatory cytokines and induces proinflammatory responses in cultured cells and mice. Mechanistically, N protein interacts directly with NLRP3 protein, promotes the binding of NLRP3 with ASC, and facilitates NLRP3 inflammasome assembly. More importantly, N protein aggravates lung injury, accelerates death in sepsis and acute inflammation mouse models, and promotes IL-1β and IL-6 activation in mice. Notably, N-induced lung injury and cytokine production are blocked by MCC950 (a specific inhibitor of NLRP3) and Ac-YVAD-cmk (an inhibitor of caspase-1). Therefore, this study reveals a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation and induces excessive inflammatory responses. SARS-CoV-2 infection has been shown to drive NLRP3 inflammasome activation and thereby cytokine storm, but how it does so is unclear. Here the authors show that the viral N protein can bind to NLRP3, resulting in enhanced interaction with ASC and thereby with the NLRP3 inflammasome.
Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. N protein facilitates maturation of proinflammatory cytokines and induces proinflammatory responses in cultured cells and mice. Mechanistically, N protein interacts directly with NLRP3 protein, promotes the binding of NLRP3 with ASC, and facilitates NLRP3 inflammasome assembly. More importantly, N protein aggravates lung injury, accelerates death in sepsis and acute inflammation mouse models, and promotes IL-1β and IL-6 activation in mice. Notably, N-induced lung injury and cytokine production are blocked by MCC950 (a specific inhibitor of NLRP3) and Ac-YVAD-cmk (an inhibitor of caspase-1). Therefore, this study reveals a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation and induces excessive inflammatory responses.Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. N protein facilitates maturation of proinflammatory cytokines and induces proinflammatory responses in cultured cells and mice. Mechanistically, N protein interacts directly with NLRP3 protein, promotes the binding of NLRP3 with ASC, and facilitates NLRP3 inflammasome assembly. More importantly, N protein aggravates lung injury, accelerates death in sepsis and acute inflammation mouse models, and promotes IL-1β and IL-6 activation in mice. Notably, N-induced lung injury and cytokine production are blocked by MCC950 (a specific inhibitor of NLRP3) and Ac-YVAD-cmk (an inhibitor of caspase-1). Therefore, this study reveals a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation and induces excessive inflammatory responses.
Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to SARS-CoV-2 infection are also associated with COVID-19 severity. Here, we show a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. N protein facilitates maturation of proinflammatory cytokines and induces proinflammatory responses in cultured cells and mice. Mechanistically, N protein interacts directly with NLRP3 protein, promotes the binding of NLRP3 with ASC, and facilitates NLRP3 inflammasome assembly. More importantly, N protein aggravates lung injury, accelerates death in sepsis and acute inflammation mouse models, and promotes IL-1β and IL-6 activation in mice. Notably, N-induced lung injury and cytokine production are blocked by MCC950 (a specific inhibitor of NLRP3) and Ac-YVAD-cmk (an inhibitor of caspase-1). Therefore, this study reveals a distinct mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation and induces excessive inflammatory responses.
SARS-CoV-2 infection has been shown to drive NLRP3 inflammasome activation and thereby cytokine storm, but how it does so is unclear. Here the authors show that the viral N protein can bind to NLRP3, resulting in enhanced interaction with ASC and thereby with the NLRP3 inflammasome.
ArticleNumber 4664
Author Luo, Zhen
Xiao, Feng
Zhang, Qiwei
Pan, Pan
Li, Geng
Wang, Jun
Wan, Pin
Lei, Zhiwei
Shen, Miaomiao
Yu, Zhenyang
Wang, Zhenwei
Zhang, Jing
Chen, Xin
Tian, Mingfu
Chen, Weijie
Wu, Jianguo
Jia, Yaling
Wang, Wenbiao
Chen, Keli
Ge, Weiwei
Xu, Meng
Li, Yongkui
Author_xml – sequence: 1
  givenname: Pan
  orcidid: 0000-0002-7214-1393
  surname: Pan
  fullname: Pan, Pan
  organization: The First Affiliated Hospital of Jinan University, Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 2
  givenname: Miaomiao
  orcidid: 0000-0002-9680-1130
  surname: Shen
  fullname: Shen, Miaomiao
  organization: State Key Laboratory of Virology, College of Life Sciences, Wuhan University
– sequence: 3
  givenname: Zhenyang
  orcidid: 0000-0003-1776-9230
  surname: Yu
  fullname: Yu, Zhenyang
  organization: State Key Laboratory of Virology, College of Life Sciences, Wuhan University
– sequence: 4
  givenname: Weiwei
  orcidid: 0000-0002-8397-7903
  surname: Ge
  fullname: Ge, Weiwei
  organization: State Key Laboratory of Virology, College of Life Sciences, Wuhan University
– sequence: 5
  givenname: Keli
  orcidid: 0000-0002-0125-3646
  surname: Chen
  fullname: Chen, Keli
  organization: State Key Laboratory of Virology, College of Life Sciences, Wuhan University
– sequence: 6
  givenname: Mingfu
  orcidid: 0000-0003-0122-6397
  surname: Tian
  fullname: Tian, Mingfu
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, State Key Laboratory of Virology, College of Life Sciences, Wuhan University
– sequence: 7
  givenname: Feng
  orcidid: 0000-0002-7895-7940
  surname: Xiao
  fullname: Xiao, Feng
  organization: State Key Laboratory of Virology, College of Life Sciences, Wuhan University
– sequence: 8
  givenname: Zhenwei
  orcidid: 0000-0002-1627-6082
  surname: Wang
  fullname: Wang, Zhenwei
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 9
  givenname: Jun
  orcidid: 0000-0003-2554-7216
  surname: Wang
  fullname: Wang, Jun
  organization: The Affiliated ShunDe Hospital of Jinan University
– sequence: 10
  givenname: Yaling
  orcidid: 0000-0003-0025-7271
  surname: Jia
  fullname: Jia, Yaling
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 11
  givenname: Wenbiao
  orcidid: 0000-0003-4944-764X
  surname: Wang
  fullname: Wang, Wenbiao
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 12
  givenname: Pin
  orcidid: 0000-0001-5374-2356
  surname: Wan
  fullname: Wan, Pin
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 13
  givenname: Jing
  orcidid: 0000-0003-1380-3948
  surname: Zhang
  fullname: Zhang, Jing
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 14
  givenname: Weijie
  orcidid: 0000-0002-4559-6317
  surname: Chen
  fullname: Chen, Weijie
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 15
  givenname: Zhiwei
  orcidid: 0000-0002-9406-2127
  surname: Lei
  fullname: Lei, Zhiwei
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 16
  givenname: Xin
  surname: Chen
  fullname: Chen, Xin
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University
– sequence: 17
  givenname: Zhen
  orcidid: 0000-0002-1142-2845
  surname: Luo
  fullname: Luo, Zhen
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Foshan Institute of Medical Microbiology
– sequence: 18
  givenname: Qiwei
  orcidid: 0000-0002-2770-111X
  surname: Zhang
  fullname: Zhang, Qiwei
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Foshan Institute of Medical Microbiology
– sequence: 19
  givenname: Meng
  orcidid: 0000-0001-7387-0734
  surname: Xu
  fullname: Xu, Meng
  organization: The First Affiliated Hospital of Jinan University
– sequence: 20
  givenname: Geng
  orcidid: 0000-0002-2441-2427
  surname: Li
  fullname: Li, Geng
  email: lg@gzucm.edu.cn
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Foshan Institute of Medical Microbiology
– sequence: 21
  givenname: Yongkui
  orcidid: 0000-0002-1532-4855
  surname: Li
  fullname: Li, Yongkui
  email: lyk070@jnu.edu.cn
  organization: Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Foshan Institute of Medical Microbiology
– sequence: 22
  givenname: Jianguo
  orcidid: 0000-0002-8326-2895
  surname: Wu
  fullname: Wu, Jianguo
  email: jwu898@jnu.edu.cn
  organization: The First Affiliated Hospital of Jinan University, Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology, Jinan University, State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Foshan Institute of Medical Microbiology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34341353$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1r3DAQFSWlSbf5Az0UQy-9uJU0smxdCmHpR2BJS9KPo5BlaaPFlraSHci_r7ybbZMcossMM-89Hpr3Eh354A1Crwl-TzA0HxIjjNclpqSkFSZVyZ-hE4oZKUlN4ehef4xOU9rg_ECQhrEX6BgYMAIVnKDfV2eXV-Uy_CppcVFsYxiN83MdcpeKi9Xldyict70aBpXCYAqlR3ejRhd8MYa86iZtiuvbrYkH2Lx7hZ5b1SdzelcX6OfnTz-WX8vVty_ny7NVqTnmY0lr0WDT8qaiTHTYUCoYEAVM5KarKcfWGopbazRYJYDU0FrVYaE7VQlbwQKd73W7oDZyG92g4q0MysndIMS1VHF0ujeS4VawmmsrwDLKmQLA0HFsVNdw0bRZ6-Neazu1g-m08WNU_QPRhxvvruU63MgGqKB0NvPuTiCGP5NJoxxc0qbvlTdhSpJWVV2xmuRLLNDbR9BNmKLPX7VDAWYcz4Jv7jv6Z-Vwvwxo9gAdQ0rRWKnduDtANuh6SbCc0yL3aZE5LXKXFskzlT6iHtSfJMGelDLYr038b_sJ1l9jrs-6
CitedBy_id crossref_primary_10_1016_j_cyto_2022_155890
crossref_primary_10_1371_journal_ppat_1012886
crossref_primary_10_3390_ijms24098034
crossref_primary_10_3390_molecules29204826
crossref_primary_10_1016_j_intimp_2024_111559
crossref_primary_10_1073_pnas_2220272120
crossref_primary_10_3389_fimmu_2023_1178662
crossref_primary_10_1016_j_ijbiomac_2024_135876
crossref_primary_10_1080_15548627_2024_2395158
crossref_primary_10_1016_j_jare_2024_11_022
crossref_primary_10_1038_s41586_022_04802_1
crossref_primary_10_3389_fimmu_2023_1259879
crossref_primary_10_1038_s41392_022_00992_2
crossref_primary_10_3390_ijms25031790
crossref_primary_10_1002_ptr_8302
crossref_primary_10_3390_vetsci11120643
crossref_primary_10_1016_j_jiph_2022_10_006
crossref_primary_10_3389_fimmu_2023_1203389
crossref_primary_10_1016_j_ijbiomac_2024_129523
crossref_primary_10_1007_s12275_022_1502_8
crossref_primary_10_14336_AD_2023_0516_1
crossref_primary_10_1080_22221751_2022_2164219
crossref_primary_10_1097_INF_0000000000003413
crossref_primary_10_33824_PJPR_2022_37_3_23
crossref_primary_10_1128_jvi_01014_23
crossref_primary_10_1038_s41392_022_01043_6
crossref_primary_10_1139_bcb_2022_0359
crossref_primary_10_3390_v15081720
crossref_primary_10_1002_jmv_28751
crossref_primary_10_1016_j_mehy_2023_111204
crossref_primary_10_1016_j_vetmic_2023_109826
crossref_primary_10_7554_eLife_94836
crossref_primary_10_3389_fcimb_2022_988604
crossref_primary_10_3390_microorganisms10030501
crossref_primary_10_1007_s13340_024_00746_1
crossref_primary_10_1038_s41392_023_01687_y
crossref_primary_10_1128_mbio_00971_22
crossref_primary_10_3389_fimmu_2025_1553093
crossref_primary_10_3389_fcimb_2022_1035711
crossref_primary_10_3389_fmicb_2023_1247377
crossref_primary_10_1016_j_tma_2023_06_005
crossref_primary_10_3390_ijms23169488
crossref_primary_10_3389_fimmu_2022_894470
crossref_primary_10_1016_j_intimp_2024_113714
crossref_primary_10_1038_s41590_021_01091_0
crossref_primary_10_1161_ATVBAHA_121_316925
crossref_primary_10_3389_fgene_2024_1385316
crossref_primary_10_3389_fphar_2024_1437475
crossref_primary_10_3390_v15071451
crossref_primary_10_3389_fcimb_2023_1134511
crossref_primary_10_3390_microorganisms11041015
crossref_primary_10_1007_s11906_022_01195_4
crossref_primary_10_1016_j_jep_2023_117512
crossref_primary_10_1126_sciimmunol_abm5505
crossref_primary_10_3389_fphar_2023_1185076
crossref_primary_10_3389_fcimb_2023_1309128
crossref_primary_10_1111_acer_14936
crossref_primary_10_3389_fimmu_2024_1440314
crossref_primary_10_3892_ijmm_2023_5238
crossref_primary_10_1002_ctm2_70098
crossref_primary_10_1038_s41380_022_01831_0
crossref_primary_10_1089_aid_2022_0152
crossref_primary_10_1002_jmr_70002
crossref_primary_10_3390_v16101646
crossref_primary_10_3389_fimmu_2023_1239572
crossref_primary_10_47360_1995_4484_2021_643_663
crossref_primary_10_1080_27694127_2022_2119743
crossref_primary_10_1016_j_envres_2024_120174
crossref_primary_10_3389_fimmu_2023_1270081
crossref_primary_10_1016_j_fsi_2022_10_017
crossref_primary_10_1126_sciimmunol_abd0205
crossref_primary_10_3389_fimmu_2023_1125246
crossref_primary_10_1038_s41392_024_01753_z
crossref_primary_10_1002_jmv_70145
crossref_primary_10_2147_JIR_S405722
crossref_primary_10_3390_v15020352
crossref_primary_10_1016_j_jgr_2022_03_008
crossref_primary_10_3390_pathogens13121109
crossref_primary_10_3390_toxics12070493
crossref_primary_10_1093_infdis_jiad037
crossref_primary_10_1016_j_jim_2024_113744
crossref_primary_10_1002_jcb_30530
crossref_primary_10_1038_s41598_021_04133_7
crossref_primary_10_1002_mco2_318
crossref_primary_10_1186_s13578_024_01237_1
crossref_primary_10_3389_fphar_2024_1402032
crossref_primary_10_1089_jir_2022_0029
crossref_primary_10_3390_nu14040782
crossref_primary_10_1016_j_gpb_2022_05_009
crossref_primary_10_1016_j_jbc_2023_104668
crossref_primary_10_1016_j_jbc_2024_107831
crossref_primary_10_3389_fimmu_2022_879792
crossref_primary_10_15212_AMM_2023_0021
crossref_primary_10_1038_s41420_024_01966_9
crossref_primary_10_1016_j_jep_2024_119074
crossref_primary_10_1016_j_intimp_2025_114222
crossref_primary_10_1186_s40779_024_00581_0
crossref_primary_10_1183_13993003_02725_2021
crossref_primary_10_1016_j_jaci_2022_05_029
crossref_primary_10_7759_cureus_35909
crossref_primary_10_1016_j_bcp_2023_115894
crossref_primary_10_1002_jgh3_12811
crossref_primary_10_1165_rcmb_2023_0207OC
crossref_primary_10_3390_microorganisms11102396
crossref_primary_10_3389_fimmu_2024_1493306
crossref_primary_10_3390_v16020213
crossref_primary_10_3390_molecules28227527
crossref_primary_10_3389_fimmu_2023_1195871
crossref_primary_10_4049_jimmunol_2300745
crossref_primary_10_1186_s12985_024_02597_3
crossref_primary_10_3390_ijms23031716
crossref_primary_10_1007_s00277_023_05164_y
crossref_primary_10_1016_j_metop_2021_100162
crossref_primary_10_1016_j_cytogfr_2024_10_001
crossref_primary_10_1038_s41392_023_01459_8
crossref_primary_10_1016_j_cej_2024_149312
crossref_primary_10_1016_j_toxlet_2024_06_004
crossref_primary_10_3390_v13122513
crossref_primary_10_1111_imr_70003
crossref_primary_10_1016_j_jointm_2024_07_004
crossref_primary_10_1016_j_molimm_2022_03_001
crossref_primary_10_3389_fimmu_2023_1231087
crossref_primary_10_1016_j_jaip_2023_02_036
crossref_primary_10_1038_s41421_024_00748_y
crossref_primary_10_1128_jvi_01909_23
crossref_primary_10_1038_s42003_023_04570_2
crossref_primary_10_1080_11101849_2022_2089518
crossref_primary_10_2144_fsoa_2022_0048
crossref_primary_10_3389_fimmu_2022_831815
crossref_primary_10_1016_j_psj_2025_104807
crossref_primary_10_3390_biomedicines9121823
crossref_primary_10_1007_s15010_023_02142_4
crossref_primary_10_1038_s41598_022_12252_y
crossref_primary_10_1016_j_gene_2024_149001
crossref_primary_10_3390_biom13101454
crossref_primary_10_1002_smll_202207066
crossref_primary_10_1126_sciimmunol_adm7908
crossref_primary_10_3389_fimmu_2023_1264447
crossref_primary_10_5812_jjm_144812
crossref_primary_10_1128_jvi_00309_22
crossref_primary_10_5114_reum_193903
crossref_primary_10_1016_j_isci_2023_108641
crossref_primary_10_3390_vetsci11110555
crossref_primary_10_3389_fimmu_2022_987453
crossref_primary_10_1038_s41467_023_43644_x
crossref_primary_10_1016_j_apsb_2024_02_011
crossref_primary_10_1038_s41392_022_01048_1
crossref_primary_10_1016_j_meegid_2024_105613
crossref_primary_10_1038_s41423_023_00985_3
crossref_primary_10_1016_j_jgr_2022_02_003
crossref_primary_10_1073_pnas_2420441122
crossref_primary_10_3390_vaccines10081307
crossref_primary_10_2147_JIR_S431222
crossref_primary_10_3390_ijms23126377
crossref_primary_10_1016_j_aquaculture_2023_740162
crossref_primary_10_1007_s00281_022_00921_z
crossref_primary_10_1165_rcmb_2023_0227ED
crossref_primary_10_1016_j_ebiom_2022_104299
crossref_primary_10_1002_2211_5463_70002
crossref_primary_10_1016_j_ailsci_2021_100020
crossref_primary_10_1016_j_heliyon_2024_e38085
crossref_primary_10_1016_j_saa_2023_123445
crossref_primary_10_31631_2073_3046_2024_23_2_94_101
crossref_primary_10_1002_advs_202411737
crossref_primary_10_1002_cti2_1404
crossref_primary_10_3390_pathogens12020243
crossref_primary_10_1002_iid3_70127
crossref_primary_10_1016_j_ebiom_2021_103803
crossref_primary_10_3390_biomedicines11082239
crossref_primary_10_3389_fphar_2023_1333389
crossref_primary_10_1016_j_ejphar_2024_176935
crossref_primary_10_1128_mbio_00951_22
crossref_primary_10_3389_fimmu_2023_1185233
crossref_primary_10_3389_fcimb_2024_1458383
crossref_primary_10_20538_1682_0363_2023_2_111_121
crossref_primary_10_3389_fmolb_2022_804109
crossref_primary_10_1371_journal_ppat_1012915
crossref_primary_10_3389_fimmu_2022_947272
crossref_primary_10_47360_1995_4484_2022_195_204
crossref_primary_10_1089_hs_2023_0008
crossref_primary_10_3390_bios13050549
crossref_primary_10_1002_advs_202103248
crossref_primary_10_1186_s12964_024_01818_0
crossref_primary_10_1016_j_isci_2023_105995
crossref_primary_10_1111_bph_17320
crossref_primary_10_1128_mbio_02388_23
crossref_primary_10_3897_pharmacia_70_e112550
crossref_primary_10_1128_jvi_00454_22
crossref_primary_10_1016_j_ijbiomac_2024_135352
crossref_primary_10_3389_fcimb_2023_1173505
crossref_primary_10_1128_msphere_00764_24
crossref_primary_10_3390_v14102113
crossref_primary_10_1002_jmv_28475
crossref_primary_10_3390_ijms24033012
crossref_primary_10_1083_jcb_202404131
crossref_primary_10_1016_j_it_2022_10_004
crossref_primary_10_1016_j_intimp_2022_108531
crossref_primary_10_1016_j_smim_2023_101781
crossref_primary_10_7554_eLife_94836_3
crossref_primary_10_1165_rcmb_2022_0351OC
crossref_primary_10_15275_rusomj_2024_0201
crossref_primary_10_3389_fimmu_2024_1332440
crossref_primary_10_3389_fmicb_2024_1490944
crossref_primary_10_3389_fimmu_2023_1249098
crossref_primary_10_1007_s11010_022_04593_z
crossref_primary_10_3389_fcimb_2023_1218039
crossref_primary_10_3389_fimmu_2022_989685
crossref_primary_10_3389_fimmu_2022_870216
crossref_primary_10_1016_j_antiviral_2024_105857
crossref_primary_10_1016_j_celrep_2024_115080
crossref_primary_10_3389_fcimb_2024_1438310
crossref_primary_10_3390_cells11030444
crossref_primary_10_31665_JFB_2022_18306
crossref_primary_10_1038_s41398_022_02052_3
crossref_primary_10_3390_ijms23084167
crossref_primary_10_1016_j_heliyon_2024_e27083
crossref_primary_10_3389_fphys_2024_1406635
crossref_primary_10_3389_fvets_2023_980187
crossref_primary_10_1186_s12951_025_03219_y
crossref_primary_10_3390_ijms23105664
crossref_primary_10_1051_medsci_2022080
crossref_primary_10_3389_fimmu_2022_842740
crossref_primary_10_1016_j_apsb_2024_03_009
crossref_primary_10_3389_fimmu_2022_1058884
crossref_primary_10_3390_ijms23137349
crossref_primary_10_3390_v15051117
crossref_primary_10_1016_j_yjmcc_2024_07_011
crossref_primary_10_1007_s10787_022_01062_3
crossref_primary_10_1186_s13046_022_02289_2
crossref_primary_10_1002_mef2_11
crossref_primary_10_1146_annurev_immunol_083122_043545
crossref_primary_10_1002_btm2_10581
crossref_primary_10_1186_s12864_024_10246_w
crossref_primary_10_1016_j_ejmcr_2023_100125
crossref_primary_10_3389_fimmu_2023_1296687
crossref_primary_10_3389_fncel_2024_1471192
crossref_primary_10_1016_j_smim_2021_101524
crossref_primary_10_3390_cells11101717
crossref_primary_10_1038_s41598_025_85733_5
crossref_primary_10_1016_j_ijbiomac_2022_09_152
crossref_primary_10_1111_sji_13239
crossref_primary_10_4049_jimmunol_2300241
crossref_primary_10_1016_j_autrev_2024_103714
crossref_primary_10_1021_acs_jmedchem_2c00649
crossref_primary_10_1038_s41598_024_53906_3
crossref_primary_10_1016_j_isci_2024_111145
crossref_primary_10_1016_j_ejphar_2021_174548
crossref_primary_10_3389_fimmu_2023_1064293
crossref_primary_10_3390_v14061137
crossref_primary_10_1016_j_trsl_2022_08_006
crossref_primary_10_3390_v15081754
crossref_primary_10_3390_hematolrep15020024
crossref_primary_10_1111_imr_13114
crossref_primary_10_1016_j_isci_2022_104046
crossref_primary_10_1128_mbio_00402_22
crossref_primary_10_1089_vim_2023_0138
crossref_primary_10_3892_mmr_2024_13173
crossref_primary_10_1016_j_intimp_2024_113006
crossref_primary_10_1186_s12929_022_00811_4
crossref_primary_10_1186_s12967_022_03767_z
crossref_primary_10_1016_j_ymthe_2022_02_014
crossref_primary_10_1002_iid3_989
crossref_primary_10_3390_ph15091046
crossref_primary_10_3390_ijms24065784
crossref_primary_10_3390_v15102018
crossref_primary_10_1080_07391102_2023_2240904
crossref_primary_10_3389_fcvm_2023_1273502
crossref_primary_10_1177_15353702231175412
crossref_primary_10_3389_fped_2022_790273
crossref_primary_10_12688_f1000research_124473_1
crossref_primary_10_1016_j_apsb_2022_09_002
crossref_primary_10_3390_ijms232314518
crossref_primary_10_3390_antib13010013
crossref_primary_10_1016_j_celrep_2022_111941
crossref_primary_10_3389_fphar_2025_1559659
crossref_primary_10_1038_s41586_022_04702_4
crossref_primary_10_1016_j_virusres_2024_199344
crossref_primary_10_1111_ane_13657
crossref_primary_10_1093_cvr_cvad084
crossref_primary_10_3390_diagnostics14060642
crossref_primary_10_1371_journal_ppat_1012546
crossref_primary_10_3389_fphar_2022_915565
crossref_primary_10_3390_v14030530
crossref_primary_10_3389_fcimb_2023_1260013
crossref_primary_10_3390_v16020273
crossref_primary_10_1002_jmv_28719
crossref_primary_10_1128_jvi_00589_23
crossref_primary_10_1186_s13073_023_01208_0
crossref_primary_10_1016_j_ijbiomac_2025_139743
crossref_primary_10_1096_fj_202401972RRR
crossref_primary_10_3389_fphar_2022_863082
crossref_primary_10_3390_v13102060
crossref_primary_10_1016_j_jaci_2023_09_020
crossref_primary_10_26508_lsa_202101226
crossref_primary_10_1002_iid3_750
crossref_primary_10_1212_NXI_0000000000200089
crossref_primary_10_1021_acsnano_3c08147
crossref_primary_10_3389_fimmu_2021_791753
crossref_primary_10_3390_biology12070943
crossref_primary_10_1093_qjmed_hcad011
crossref_primary_10_1016_j_tim_2021_11_011
crossref_primary_10_1038_s41392_021_00742_w
crossref_primary_10_1186_s41232_023_00259_5
crossref_primary_10_1089_vim_2022_0060
crossref_primary_10_1038_s41380_021_01431_4
crossref_primary_10_3389_fimmu_2023_1244556
crossref_primary_10_1080_25785826_2022_2066251
crossref_primary_10_3390_cells12071092
crossref_primary_10_1016_j_ymthe_2022_12_002
crossref_primary_10_1038_s41564_023_01586_6
crossref_primary_10_1002_adbi_202200336
crossref_primary_10_3390_biomedicines11040999
crossref_primary_10_1002_smtd_202300044
crossref_primary_10_1186_s12985_024_02506_8
crossref_primary_10_3390_v15030639
crossref_primary_10_1128_jvi_00869_24
crossref_primary_10_3389_fimmu_2022_896353
crossref_primary_10_3389_fmicb_2021_759198
crossref_primary_10_3390_v15122434
crossref_primary_10_1016_j_it_2022_02_001
crossref_primary_10_1038_s41392_022_01249_8
crossref_primary_10_1126_sciimmunol_add4906
crossref_primary_10_1080_02656736_2022_2093994
crossref_primary_10_1038_s41467_024_46322_8
crossref_primary_10_1016_j_cellsig_2025_111635
crossref_primary_10_1371_journal_pone_0302818
crossref_primary_10_1007_s10875_021_01142_z
crossref_primary_10_1007_s00705_022_05513_8
crossref_primary_10_3389_fmicb_2021_770656
crossref_primary_10_1016_j_celrep_2024_114478
Cites_doi 10.1038/s41586-019-1295-z
10.1038/s41594-020-0468-7
10.1038/nrgastro.2015.94
10.1128/JVI.01925-19
10.15252/embj.2020105938
10.1128/JVI.00996-19
10.1038/s41564-020-0695-z
10.1038/s41577-020-0311-8
10.1038/srep24166
10.3389/fmicb.2019.02637
10.1016/S0140-6736(20)31142-9
10.1038/ni.3015
10.1016/S0140-6736(20)30628-0
10.1126/science.1240248
10.1016/j.virol.2015.08.010
10.1146/annurev.immunol.021908.132715
10.1007/s11427-020-1692-1
10.1096/fj.201801681R
10.1038/s41467-017-02645-3
10.1097/CM9.0000000000000722
10.3389/fmicb.2019.00050
10.1007/s00011-020-01413-2
10.1038/nrd.2018.149
10.1016/j.immuni.2020.04.023
10.1371/journal.ppat.1005973
10.1016/S0140-6736(20)30251-8
10.1038/nrrheum.2016.166
10.1007/s13238-013-3905-0
10.1172/JCI137244
10.3390/ijms20133328
10.1038/nri3452
10.1084/jem.20201707
10.1016/S0140-6736(20)30183-5
10.1038/nri.2016.58
10.1038/s41467-020-17687-3
10.3389/fimmu.2020.01626
10.1126/scisignal.3105cm2
10.1016/j.lfs.2020.118054
10.1126/scisignal.3105cm1
10.1084/jem.20200678
10.1056/NEJMoa2001316
ContentType Journal Article
Copyright The Author(s) 2021. corrected publication 2021
2021. The Author(s).
The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021, corrected publication 2021
Copyright_xml – notice: The Author(s) 2021. corrected publication 2021
– notice: 2021. The Author(s).
– notice: The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021, corrected publication 2021
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-021-25015-6
DatabaseName Springer Nature OA/Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

MEDLINE - Academic
CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 17
ExternalDocumentID oai_doaj_org_article_40b9476cf93f4264a3303d60ead8698b
PMC8329225
34341353
10_1038_s41467_021_25015_6
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 81730061
  funderid: https://doi.org/10.13039/501100001809
– fundername: Guangdong Province Introduction of Innovative R&D Team (Introduction of Innovative R&D Team Program of Guangdong Province)
  grantid: 2017ZT07Y580
  funderid: https://doi.org/10.13039/100012540
– fundername: ;
  grantid: 81730061
– fundername: ;
  grantid: 2017ZT07Y580
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
SOI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c606t-27980eb685249d0e229431a349294d7260ffe20bfec3fa93173bfad09cda59f53
IEDL.DBID 7X7
ISSN 2041-1723
IngestDate Wed Aug 27 01:32:07 EDT 2025
Thu Aug 21 14:09:56 EDT 2025
Tue Aug 05 11:04:54 EDT 2025
Wed Aug 13 07:38:37 EDT 2025
Thu Apr 03 07:00:32 EDT 2025
Thu Apr 24 23:08:10 EDT 2025
Tue Jul 01 04:17:32 EDT 2025
Fri Feb 21 02:39:14 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2021. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c606t-27980eb685249d0e229431a349294d7260ffe20bfec3fa93173bfad09cda59f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9406-2127
0000-0002-7214-1393
0000-0002-2770-111X
0000-0002-9680-1130
0000-0002-0125-3646
0000-0003-2554-7216
0000-0003-1380-3948
0000-0002-1142-2845
0000-0001-7387-0734
0000-0002-7895-7940
0000-0002-8397-7903
0000-0002-1627-6082
0000-0003-4944-764X
0000-0002-8326-2895
0000-0003-1776-9230
0000-0002-4559-6317
0000-0003-0122-6397
0000-0003-0025-7271
0000-0002-2441-2427
0000-0002-1532-4855
0000-0001-5374-2356
OpenAccessLink https://www.proquest.com/docview/2557304605?pq-origsite=%requestingapplication%
PMID 34341353
PQID 2557304605
PQPubID 546298
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_40b9476cf93f4264a3303d60ead8698b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8329225
proquest_miscellaneous_2557547100
proquest_journals_2557304605
pubmed_primary_34341353
crossref_citationtrail_10_1038_s41467_021_25015_6
crossref_primary_10_1038_s41467_021_25015_6
springer_journals_10_1038_s41467_021_25015_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-08-02
PublicationDateYYYYMMDD 2021-08-02
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-02
  day: 02
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Schett, Dayer, Manger (CR38) 2016; 12
Chen, Moriyama, Chang, Ichinohe (CR24) 2019; 10
Mangan (CR11) 2018; 17
Ni (CR35) 2020; 52
CR18
Tay (CR25) 2020; 20
Gorbalenya (CR2) 2020; 5
CR17
Lu (CR22) 2020; 395
Nieto-Torres (CR23) 2015; 485
Broz, Dixit (CR12) 2016; 16
Li (CR1) 2020; 382
Ren (CR21) 2020; 133
Szabo, Petrasek (CR10) 2015; 12
Kayagaki (CR40) 2013; 341
Huang (CR5) 2020; 395
Wrobel (CR3) 2020; 27
Latz, Xiao, Stutz (CR16) 2013; 13
Mu (CR34) 2020; 63
Chu (CR6) 2020; 395
Wang, Mao, Meng (CR28) 2013; 4
Pan (CR37) 2019; 10
Pan (CR14) 2019; 93
Rodrigues (CR19) 2021; 218
Chen (CR39) 2020; 130
CR4
Wang (CR13) 2014; 15
CR8
CR7
CR9
Zhang (CR31) 2016; 6
Cong (CR32) 2020; 94
Martinon, Mayor, Tschopp (CR27) 2009; 27
Mehta (CR26) 2020; 395
Kelley, Jeltema, Duan, He (CR15) 2019; 20
Peng (CR33) 2020; 39
Sharif (CR29) 2019; 570
Slaats, Ten Oever, van de Veerdonk, Netea (CR36) 2016; 12
Toldo (CR20) 2021; 70
Wan (CR41) 2019; 33
Wang (CR30) 2018; 9
25015_CR8
25015_CR7
JL Nieto-Torres (25015_CR23) 2015; 485
25015_CR9
25015_CR4
X Wang (25015_CR13) 2014; 15
DK Chu (25015_CR6) 2020; 395
R Lu (25015_CR22) 2020; 395
H Sharif (25015_CR29) 2019; 570
P Broz (25015_CR12) 2016; 16
TS Rodrigues (25015_CR19) 2021; 218
P Wan (25015_CR41) 2019; 33
Y Cong (25015_CR32) 2020; 94
H Wang (25015_CR28) 2013; 4
M Mangan (25015_CR11) 2018; 17
L Ren (25015_CR21) 2020; 133
S Toldo (25015_CR20) 2021; 70
W Wang (25015_CR30) 2018; 9
F Zhang (25015_CR31) 2016; 6
F Martinon (25015_CR27) 2009; 27
Q Li (25015_CR1) 2020; 382
C Huang (25015_CR5) 2020; 395
AE Gorbalenya (25015_CR2) 2020; 5
G Schett (25015_CR38) 2016; 12
L Ni (25015_CR35) 2020; 52
P Pan (25015_CR37) 2019; 10
P Mehta (25015_CR26) 2020; 395
Matthew Zirui Tay (25015_CR25) 2020; 20
N Kayagaki (25015_CR40) 2013; 341
AG Wrobel (25015_CR3) 2020; 27
N Kelley (25015_CR15) 2019; 20
P Pan (25015_CR14) 2019; 93
G Chen (25015_CR39) 2020; 130
G Szabo (25015_CR10) 2015; 12
J Mu (25015_CR34) 2020; 63
J Slaats (25015_CR36) 2016; 12
25015_CR17
IY Chen (25015_CR24) 2019; 10
Y Peng (25015_CR33) 2020; 39
25015_CR18
E Latz (25015_CR16) 2013; 13
34465791 - Nat Commun. 2021 Aug 31;12(1):5306
References_xml – volume: 570
  start-page: 338
  year: 2019
  end-page: 343
  ident: CR29
  article-title: Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
  publication-title: Nature
  doi: 10.1038/s41586-019-1295-z
– ident: CR18
– volume: 27
  start-page: 763
  year: 2020
  end-page: 767
  ident: CR3
  article-title: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/s41594-020-0468-7
– volume: 12
  start-page: 387
  year: 2015
  end-page: 400
  ident: CR10
  article-title: Inflammasome activation and function in liver disease
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/nrgastro.2015.94
– ident: CR4
– volume: 94
  start-page: e01925
  year: 2020
  end-page: 19
  ident: CR32
  article-title: Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle
  publication-title: J. Virol.
  doi: 10.1128/JVI.01925-19
– volume: 39
  start-page: e105938
  year: 2020
  ident: CR33
  article-title: Structures of theSARS-CoV-2 nucleocapsid and their perspectives for drug design
  publication-title: EMBO J.
  doi: 10.15252/embj.2020105938
– volume: 93
  start-page: e00996
  year: 2019
  end-page: 19
  ident: CR14
  article-title: Dengue virus M protein promotes NLRP3 inflammasome activation to induce vascular leakage in mice
  publication-title: J. Virol.
  doi: 10.1128/JVI.00996-19
– volume: 5
  start-page: 536
  year: 2020
  end-page: 544
  ident: CR2
  article-title: The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0695-z
– volume: 20
  start-page: 363
  year: 2020
  end-page: 374
  ident: CR25
  article-title: The trinity of COVID-19: immunity, inflammation and intervention
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0311-8
– volume: 6
  year: 2016
  ident: CR31
  article-title: The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities
  publication-title: Sci. Rep.
  doi: 10.1038/srep24166
– volume: 10
  start-page: 2637
  year: 2019
  ident: CR37
  article-title: Dengue virus infection activates interleukin-1beta to induce tissue injury and vascular leakage
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.02637
– volume: 395
  start-page: 1973
  year: 2020
  end-page: 1987
  ident: CR6
  article-title: Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31142-9
– volume: 15
  start-page: 1126
  year: 2014
  end-page: 1133
  ident: CR13
  article-title: RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3015
– volume: 395
  start-page: 1033
  year: 2020
  end-page: 1034
  ident: CR26
  article-title: COVID-19: consider cytokine storm syndromes and immunosuppression
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30628-0
– volume: 341
  start-page: 1246
  year: 2013
  end-page: 1249
  ident: CR40
  article-title: Noncanonical inflammasome activation by intracellular LPS independent of TLR4
  publication-title: Science
  doi: 10.1126/science.1240248
– volume: 485
  start-page: 330
  year: 2015
  end-page: 339
  ident: CR23
  article-title: Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
  publication-title: Virology
  doi: 10.1016/j.virol.2015.08.010
– volume: 27
  start-page: 229
  year: 2009
  end-page: 265
  ident: CR27
  article-title: The inflammasomes: guardians of the body
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.021908.132715
– ident: CR8
– volume: 63
  start-page: 1413
  year: 2020
  end-page: 1416
  ident: CR34
  article-title: SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells
  publication-title: Sci. China Life Sci.
  doi: 10.1007/s11427-020-1692-1
– volume: 33
  start-page: 5793
  year: 2019
  end-page: 5807
  ident: CR41
  article-title: Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation
  publication-title: Faseb J.
  doi: 10.1096/fj.201801681R
– volume: 9
  year: 2018
  ident: CR30
  article-title: Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1beta secretion
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-02645-3
– volume: 133
  start-page: 1015
  year: 2020
  end-page: 1024
  ident: CR21
  article-title: Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
  publication-title: Chin. Med. J. Peking.
  doi: 10.1097/CM9.0000000000000722
– volume: 10
  start-page: 50
  year: 2019
  ident: CR24
  article-title: Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.00050
– volume: 70
  start-page: 7
  year: 2021
  end-page: 10
  ident: CR20
  article-title: Inflammasome formation in the lungs of patients with fatal COVID-19
  publication-title: Inflamm. Res.
  doi: 10.1007/s00011-020-01413-2
– volume: 382
  start-page: 1199
  year: 2020
  end-page: 1207
  ident: CR1
  article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
  publication-title: N. Engl. J. Med.
– volume: 17
  start-page: 688
  year: 2018
  ident: CR11
  article-title: Targeting the NLRP3 inflammasome in inflammatory diseases
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2018.149
– volume: 52
  start-page: 971
  year: 2020
  ident: CR35
  article-title: Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.023
– volume: 12
  start-page: e1005973
  year: 2016
  ident: CR36
  article-title: IL-1 beta/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1005973
– ident: CR17
– volume: 395
  start-page: 565
  year: 2020
  end-page: 574
  ident: CR22
  article-title: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30251-8
– volume: 12
  start-page: 14
  year: 2016
  end-page: 24
  ident: CR38
  article-title: Interleukin-1 function and role in rheumatic disease
  publication-title: Nat. Rev. Rheumatol.
  doi: 10.1038/nrrheum.2016.166
– ident: CR9
– volume: 4
  start-page: 565
  year: 2013
  end-page: 568
  ident: CR28
  article-title: The NLRP3 inflammasome activation in human or mouse cells, sensitivity causes puzzle
  publication-title: Protein Cell.
  doi: 10.1007/s13238-013-3905-0
– volume: 130
  start-page: 2620
  year: 2020
  end-page: 2629
  ident: CR39
  article-title: Clinical and immunological features of severe and moderate coronavirus disease 2019
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI137244
– volume: 20
  start-page: 3328
  year: 2019
  ident: CR15
  article-title: The NLRP3 inflammasome: an overview of mechanisms of activation and regulation
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20133328
– ident: CR7
– volume: 13
  start-page: 397
  year: 2013
  end-page: 411
  ident: CR16
  article-title: Activation and regulation of the inflammasomes
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3452
– volume: 218
  start-page: e20201707
  year: 2021
  ident: CR19
  article-title: Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20201707
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: CR5
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 16
  start-page: 407
  year: 2016
  end-page: 420
  ident: CR12
  article-title: Inflammasomes: mechanism of assembly, regulation and signalling
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2016.58
– volume: 15
  start-page: 1126
  year: 2014
  ident: 25015_CR13
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3015
– volume: 130
  start-page: 2620
  year: 2020
  ident: 25015_CR39
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI137244
– volume: 17
  start-page: 688
  year: 2018
  ident: 25015_CR11
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd.2018.149
– volume: 395
  start-page: 565
  year: 2020
  ident: 25015_CR22
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30251-8
– volume: 5
  start-page: 536
  year: 2020
  ident: 25015_CR2
  publication-title: Nat. Microbiol.
  doi: 10.1038/s41564-020-0695-z
– ident: 25015_CR4
  doi: 10.1038/s41467-020-17687-3
– volume: 10
  start-page: 50
  year: 2019
  ident: 25015_CR24
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.00050
– volume: 39
  start-page: e105938
  year: 2020
  ident: 25015_CR33
  publication-title: EMBO J.
  doi: 10.15252/embj.2020105938
– volume: 70
  start-page: 7
  year: 2021
  ident: 25015_CR20
  publication-title: Inflamm. Res.
  doi: 10.1007/s00011-020-01413-2
– ident: 25015_CR8
  doi: 10.3389/fimmu.2020.01626
– volume: 570
  start-page: 338
  year: 2019
  ident: 25015_CR29
  publication-title: Nature
  doi: 10.1038/s41586-019-1295-z
– volume: 63
  start-page: 1413
  year: 2020
  ident: 25015_CR34
  publication-title: Sci. China Life Sci.
  doi: 10.1007/s11427-020-1692-1
– volume: 27
  start-page: 229
  year: 2009
  ident: 25015_CR27
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.021908.132715
– volume: 133
  start-page: 1015
  year: 2020
  ident: 25015_CR21
  publication-title: Chin. Med. J. Peking.
  doi: 10.1097/CM9.0000000000000722
– volume: 9
  year: 2018
  ident: 25015_CR30
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-02645-3
– volume: 27
  start-page: 763
  year: 2020
  ident: 25015_CR3
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/s41594-020-0468-7
– volume: 395
  start-page: 1033
  year: 2020
  ident: 25015_CR26
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30628-0
– volume: 10
  start-page: 2637
  year: 2019
  ident: 25015_CR37
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.02637
– volume: 218
  start-page: e20201707
  year: 2021
  ident: 25015_CR19
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20201707
– ident: 25015_CR18
  doi: 10.1126/scisignal.3105cm2
– volume: 94
  start-page: e01925
  year: 2020
  ident: 25015_CR32
  publication-title: J. Virol.
  doi: 10.1128/JVI.01925-19
– volume: 12
  start-page: 14
  year: 2016
  ident: 25015_CR38
  publication-title: Nat. Rev. Rheumatol.
  doi: 10.1038/nrrheum.2016.166
– volume: 341
  start-page: 1246
  year: 2013
  ident: 25015_CR40
  publication-title: Science
  doi: 10.1126/science.1240248
– ident: 25015_CR7
  doi: 10.1016/j.lfs.2020.118054
– volume: 395
  start-page: 497
  year: 2020
  ident: 25015_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 12
  start-page: e1005973
  year: 2016
  ident: 25015_CR36
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1005973
– volume: 16
  start-page: 407
  year: 2016
  ident: 25015_CR12
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2016.58
– ident: 25015_CR17
  doi: 10.1126/scisignal.3105cm1
– volume: 4
  start-page: 565
  year: 2013
  ident: 25015_CR28
  publication-title: Protein Cell.
  doi: 10.1007/s13238-013-3905-0
– volume: 52
  start-page: 971
  year: 2020
  ident: 25015_CR35
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.023
– ident: 25015_CR9
  doi: 10.1084/jem.20200678
– volume: 20
  start-page: 3328
  year: 2019
  ident: 25015_CR15
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20133328
– volume: 13
  start-page: 397
  year: 2013
  ident: 25015_CR16
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3452
– volume: 20
  start-page: 363
  year: 2020
  ident: 25015_CR25
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0311-8
– volume: 6
  year: 2016
  ident: 25015_CR31
  publication-title: Sci. Rep.
  doi: 10.1038/srep24166
– volume: 395
  start-page: 1973
  year: 2020
  ident: 25015_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31142-9
– volume: 12
  start-page: 387
  year: 2015
  ident: 25015_CR10
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/nrgastro.2015.94
– volume: 93
  start-page: e00996
  year: 2019
  ident: 25015_CR14
  publication-title: J. Virol.
  doi: 10.1128/JVI.00996-19
– volume: 485
  start-page: 330
  year: 2015
  ident: 25015_CR23
  publication-title: Virology
  doi: 10.1016/j.virol.2015.08.010
– volume: 382
  start-page: 1199
  year: 2020
  ident: 25015_CR1
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2001316
– volume: 33
  start-page: 5793
  year: 2019
  ident: 25015_CR41
  publication-title: Faseb J.
  doi: 10.1096/fj.201801681R
– reference: 34465791 - Nat Commun. 2021 Aug 31;12(1):5306
SSID ssj0000391844
Score 2.7095888
Snippet Excessive inflammatory responses induced upon SARS-CoV-2 infection are associated with severe symptoms of COVID-19. Inflammasomes activated in response to...
SARS-CoV-2 infection has been shown to drive NLRP3 inflammasome activation and thereby cytokine storm, but how it does so is unclear. Here the authors show...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4664
SubjectTerms 13/109
13/21
13/51
13/89
14/19
38
42
45
45/111
631/250/254
631/250/256/2177
631/326/596/2553
82/51
96/95
Animal models
Animals
Caspase-1
Cells, Cultured
Coronavirus Nucleocapsid Proteins - metabolism
Coronaviruses
COVID-19
COVID-19 - metabolism
COVID-19 - virology
Cytokine storm
Cytokines
Cytokines - metabolism
HEK293 Cells
Humanities and Social Sciences
Humans
IL-1β
Infections
Inflammasomes
Inflammasomes - genetics
Inflammasomes - metabolism
Inflammation
Inflammation - metabolism
Inhibitors
Interleukin 6
Lung Injury - genetics
Lung Injury - metabolism
Lungs
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
multidisciplinary
N protein
NLR Family, Pyrin Domain-Containing 3 Protein - genetics
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
Phosphoproteins - metabolism
Protein Binding
Proteins
SARS-CoV-2 - metabolism
SARS-CoV-2 - physiology
Science
Science (multidisciplinary)
Sepsis
Severe acute respiratory syndrome coronavirus 2
THP-1 Cells
Viral diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA5SEHwR63W0SgTfNDSdXCZ5rMVSRBdprfYtJJOEFtoZcbcP_fc9J5ldu15ffBrYZJnw5VwnJ98h5BVS3EUVDItBCyZD7FloecdSNlxlCCi8x7vDH2f64Fi-P1EnN1p9YU1YpQeuwG1LHqzsdJ-tyOi9PSTgImoOCBhtTUDrCz7vRjJVbLCwkLrI6ZYMF2Z7LotNwIoE8Po7iuk1T1QI-38XZf5aLPnTiWlxRPv3yN0pgqS7deWb5FYa7pPbtafk1QPy9Wj38IjtjV9YS2e00DCcDfiEPUlzOvtw-ElQECuQhAs_Hy8SxasN9cMsXYwwFGG36ekVUiBP03DsITnef_d574BN3RNYD0nJgrWdNTwFbRRkWJGntrUQLHhkI7QydpDH5JxaHnLqRfYW4ggRso_c9tErm5V4RDaGcUhPCDVe6GwzZDa-k32IHsDgUWODatsbGRuys0TS9RO1OHa4OHfliFsYV9F3gL4r6DvdkNer_3yrxBp_nf0WN2g1E0mxyw8gKm4SFfcvUWnI1nJ73aSpc3iB6urpcENeroZBx_DgxA9pvKxzlEQepIY8rtKwWomQGAco0ZBuTU7Wlro-MpydFh5vMKYWzGlD3iwl6sey_gzF0_8BxTNyp0VVwNqXdotsLL5fpucQXS3Ci6JI12ufHbw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB6VIiQuiDcpBQWJGxjS-BH7gFCpqCpEV6hlobfIjm1aqU3o7lZi_z0zTnbRwtJTpNhW7PGM55vY_gbgJVHceek0805xJpxvmCuLioWoCxkRUFhLd4cPR-pgLD6dyJMNWKQ7GgQ4XRvaUT6p8eT8za_L-Xs0-Hf9lXH9diqSudNhA3ToO5KpG3ATPVNFhno4wP20MnODAY0Y7s6sb7rinxKN_zrs-e8Ryr_2UZN72r8LdwZcme_2inAPNkJ7H271mSbnD-D78e7RMdvrvrEyH-WJnOGspSfOVJjmo89HX3iOw0f9uLDT7iLkdOGh_12bzzos8qgD-emciJGHalT2EMb7H7_uHbAhpwJrMFSZsbIyughOaYlxly9CWRqEEJY4Co3wFUY3MYaycDE0PFqD6IK7aH1hGm-liZI_gs22a8MTyLXlKpqI8Y6tROO8RWEUXlHaatNo4TPYWUiybgbCccp7cV6njW-u6176NUq_TtKvVQavlm1-9nQb19b-QBO0rElU2elFN_lRD5ZXi8IZUakmGh4J_lmOXturAk1IK6NdBtuL6a0X6ocfkFW_Z5zBi2UxWh5tp9g2dFd9HSmIHSmDx702LHvCBaEDyTOoVvRkpaurJe3ZaWL3xiXW4CKbweuFRv3p1v9FsXX9KJ7C7ZKUnM66lNuwOZtchWeIpmbueTKR30LHGPQ
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA/Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VIiQuiDcpBQWJG1i48SP2sayoKgQr1FLoLbJju61EE9TdHvrvO-NkgxYKEqdImYlizcMztsffALwmiLugvGHBa8GkDy3zFa9ZTIarhAmFc3R3-PNc7x_Jj8fqeAOq1V2YXLSfIS3zNL2qDnu3kNmlqaAAg_aOYvoW3CbodrLqmZ5N-yqEeG6kHO_HcGFu-HQtBmWo_pvyyz_LJH87K80haO8-3Btzx3J3GO0D2IjdQ7gzdJO8egTfD3cPDtms_8aqcl5mAIazjp6ojbgo558OvogSDQpt4Nwt-vNY0qWGYUu2XPZICqjn8vSKwI9HNqI9hqO9D19n-2zsm8BaXI4sWVVbw6PXRuHaKvBYVRbTBEc4hFaGGlcwKcWK-xRbkZzFDEL45AK3bXDKJiWewGbXd_EZlMYJnWzCNY2rZeuDQ2HwoKk1tW2NDAXsrCTZtCOoOPW2-NHkw21hmkH6DUq_ydJvdAFvpm9-DpAa_-R-TwqaOAkOO7_oL06a0Twayb2VtW6TFYlSPCcwMgfN0U2MtsYXsL1SbzP66AJ_oOrhXLiAVxMZvYuOTFwX-8uBR0lCQCrg6WAN00iEpAxAiQLqNTtZG-o6pTs7zQjeOI1anEgLeLuyqF_D-rsotv6P_Tncrcjoqb6l2obN5cVlfIEZ1NK_zC5zDa_cE48
  priority: 102
  providerName: Springer Nature
Title SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
URI https://link.springer.com/article/10.1038/s41467-021-25015-6
https://www.ncbi.nlm.nih.gov/pubmed/34341353
https://www.proquest.com/docview/2557304605
https://www.proquest.com/docview/2557547100
https://pubmed.ncbi.nlm.nih.gov/PMC8329225
https://doaj.org/article/40b9476cf93f4264a3303d60ead8698b
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBdby2AvY99z1wUP9raJupYsS08jDc1KWENJ1i1vRrKktbDabZ0-9L_fnaykZB99scFSQLkvne5OvyPkA0Lc2cJIao1glBtbU5NnJXVeZoUHh0JrvDt8PBVHp3yyKBYx4NbFssqVTQyG2rY1xsj3wPUt-yze58sril2jMLsaW2g8JNsIXYYlXeWiXMdYEP1cch7vymRM7nU8WAasS4C9f7-gYmM_CrD9__I1_y6Z_CNvGraj8VPyJPqR6bBn_DPywDXPyaO-s-TtC_JjPpzN6aj9TvN0mgYwhvMG38AZ16XTr7MTloJwgTxc6K69cClecOjDs-myhSELPE_PbhEIOU7DsZfkdHz4bXREYw8FWsPRZEnzUsnMGSELOGfZzOW5ApdBIyah4raE04z3Ls-MdzXzWoE3wYzXNlO11YXyBXtFtpq2cW9IKjUTXnk43-iS18ZqIEZmBbapVrXkNiH7K0pWdQQYxz4Xv6qQ6Gay6qlfAfWrQP1KJOTj-jeXPbzGvbMPkEHrmQiNHT601z-rqGkVz4zipai9Yh7dPc1gl7YiA5WRQkmTkN0Ve6uor111J10Jeb8eBk3D9IluXHvTzyk4oiEl5HUvDeuVMI7eQMESUm7IycZSN0ea87OA5g0mVYFRTcinlUTdLev_pNi5_1-8JY9zFHKsbcl3ydby-sa9A-9paQZBReApx18GZHs4nMwn8D44nJ7M4OtIjAYhLgHPYy5_A3f0HIU
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgQXxJtAgSDBCay6sZPYB4RKodrS7Qr1AXtz7dimlWhSmq3Q_il-IzN5Vcujt54ixY7kjL8Zf359Q8hLlLhzqZXU2YxTYV1BbcJy6oNkaQBCYQzeHd6ZZKMD8WmaTpfIr_4uDB6r7GNiE6hdVeAa-SpQ37zdxXt3-oNi1ijcXe1TaLSw2PbznzBlq99ufYD-fZUkmx_3N0a0yypACyDrM5rkSjJvM5nCzMMxnyQKBlGDKn1KuBz4fQg-YTb4ggejYHzlNhjHVOFMqgJmiYCQfw2-YehR-TQf1nRQbV0K0d3NYVyu1qKJRHgOArjGWkqzhfGvSRPwL2779xHNP_Zpm-Fv8za51fHWeL0F2h2y5Mu75HqbyXJ-j3zdW9_doxvVF5rEk7gRfzgu8QlI8HU8Ge9-5jGAGfB3YurqxMd4oaJdDo5nFRQ5wFh8NEfh5a4alt0nB1di3QdkuaxK_4jE0vAsqADzKZOLwjoDxmAuw7TYqpDCRWStt6QuOkFzzKvxXTcb61zq1voarK8b6-ssIq-Hb05bOY9La7_HDhpqohR386I6-6Y7z9aCWSXyrAiKB6SXhgMrcBkDF5WZkjYiK3336i4-1PoCzRF5MRSDZ-N2jSl9dd7WSQWqL0XkYYuGoSVcIPtIeUTyBZwsNHWxpDw-atTDIYQrCOIRedMj6qJZ_zfF48v_4jm5MdrfGevx1mT7CbmZIODxXE2yQpZnZ-f-KTC3mX3WuEtMDq_aP38DDXlSIA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VRSAuiDcLBRYJTmB1s_bu2geESkvU0hJVLYXcXHtt00p0tzSpUP4av46ZfaQKj956ihQ7kjP-ZvzZY38D8JIk7lxmJXM250xYVzKbJgXzQSZZQEJhDL0d_jTKNw_Ex3E2XoJf_VsYulbZx8QmULu6pDPyVaS-RZvFWw3dtYjdjeG70x-MKkhRprUvp9FCZNvPfuL2bfJ2awPn-lWaDj98Xt9kXYUBViJxn7K0UDLxNpcZ7kJc4tNU4YJqSLFPCVcg1w_Bp4kNvuTBKFxruQ3GJap0JlOBKkZg-L9W8GxAPlaMi_n5DimvSyG6dzoJl6sT0UQluhOBvGOQsXxhLWxKBvyL5_59XfOPnG2zFA5vw62Ow8ZrLejuwJKv7sL1tqrl7B583V_b22fr9ReWxqO4EYI4rugTUeEn8Whnb5fHCGzE4omZ1Cc-pscV7dFwPK2xySHe4qMZiTB33ajtPhxciXUfwHJVV_4RxNLwPKiAeytTiNI6g8ZIXE4lslUphYtg0FtSl524OdXY-K6bJDuXurW-Ruvrxvo6j-D1_DenrbTHpb3f0wTNe5Isd_NFffZNd16uRWKVKPIyKB6IahqODMHlCbqrzJW0Eaz006u7WDHRF8iO4MW8Gb2cUjem8vV52ycTpMQUwcMWDfORcEFMJOMRFAs4WRjqYkt1fNQoiWM4VxjQI3jTI-piWP83xePL_8VzuIGeqXe2RttP4GZKeKcrNukKLE_Pzv1TJHFT-6zxlhgOr9o9fwP_mFZW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+N+protein+promotes+NLRP3+inflammasome+activation+to+induce+hyperinflammation&rft.jtitle=Nature+communications&rft.au=Pan%2C+Pan&rft.au=Shen+Miaomiao&rft.au=Yu%2C+Zhenyang&rft.au=Ge+Weiwei&rft.date=2021-08-02&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-021-25015-6&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon